시장보고서
상품코드
1978879

금속 살생물제 시장 : 유형, 형태, 용도, 최종 이용 산업, 유통 채널별 - 세계 예측(2026-2032년)

Metal Biocides Market by Type, Form, Application, End Use Industry, Distribution Channel - Global Forecast 2026-2032

발행일: | 리서치사: 구분자 360iResearch | 페이지 정보: 영문 188 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

금속 살생물제 시장은 2025년에 41억 8,000만 달러로 평가되었습니다. 2026년에는 44억 3,000만 달러에 이르고, CAGR 6.31%를 나타내 2032년까지 64억 1,000만 달러에 달할 것으로 예측됩니다.

주요 시장 통계
기준 연도(2025년) 41억 8,000만 달러
추정 연도(2026년) 44억 3,000만 달러
예측 연도(2032년) 64억 1,000만 달러
CAGR(%) 6.31%

규제 압력, 혁신 촉진요인 및 전략적 결정을 형성하는 최종 사용자 수요를 중심으로 금속 살균제 시장 역학에 대한 간략한 개요를 제공합니다.

금속 살생물제 시장은 전통적인 화학 기술, 진화하는 규제, 그리고 지속적인 항균 성능에 대한 수요 증가가 교차하는 지점에 위치하고 있습니다. 최근 성분의 안전성 및 환경 잔류성에 대한 감시가 강화되고 있으며, 이로 인해 제제 제조업체와 다운스트림 사용자는 원료 조달, 대체 경로 및 규정 준수 의무에 대한 재평가를 요구받고 있습니다. 동시에, 용도별 화학 기술 및 전달 시스템의 혁신은 코팅, 폴리머 안정화, 퍼스널케어, 수처리 분야에서 새로운 성능 우위를 가져다주고 있습니다.

기술, 규제, 지속가능성 분야의 혁신적 전환이 금속 살균제 가치사슬 전반에서 성능, 조달, 경쟁 차별화를 재정의하는 방법

규제 강화, 지속가능성에 대한 노력, 그리고 타겟팅된 혁신에 힘입어 원료에서 완제품에 이르는 가치사슬을 재구성하는 변혁적 변화가 일어나고 있습니다. 규제 당국은 환경에서의 거동, 인체 노출 및 장기 잔류성에 대한 관심을 강화하고 있으며, 이로 인해 공급업체들은 대체 화학물질, 보다 강력한 독성 데이터 세트 및 관리 프로그램에 투자해야 하는 상황에 직면해 있습니다. 동시에, OEM 제조업체와 시공업체들은 수명주기 영향과 입증 가능한 성능에 점점 더 많은 관심을 기울이고 있으며, 이는 제형 제조업체들이 환경 방출을 줄이는 저용량 솔루션과 캡슐화 기술로 전환하도록 유도하고 있습니다.

미국의 새로운 관세 조치와 무역 정책 전환이 금속 살생물제 조달 및 물류에 미치는 운영, 비용, 공급망 측면의 누적 영향을 예측합니다.

관세 조치와 무역 정책의 조정이 단계적으로 도입됨에 따라 조달, 물류, 가격 책정 메커니즘에 영향을 미치고 있으며, 기업들은 공급업체의 거점 구성과 재고 전략을 재검토해야 하는 상황에 직면해 있습니다. 관세로 인한 비용 이동은 원재료 공급 집중, 운송 병목 현상, 기능성 유효 성분의 제한된 대안과 같은 기존 제약과 함께 더욱 확대되는 추세입니다. 이에 따라 조달팀은 단일 국가에 대한 의존도를 줄이고 공급의 연속성을 보장하기 위해 지리적 분산, 니어쇼어링 또는 멀티소싱과 같은 전략을 추구하는 경우가 많습니다.

제품 포지셔닝 및 연구개발(R& : D) 우선순위에 미치는 용도, 유형, 형태, 최종 사용 산업, 유통채널에 미치는 영향을 파악하는 전략적 세분화 관점

엄격한 세분화를 통해 사업을 세분화하면 기술 요구 사항과 상업적 레버리지가 크게 다른 영역과 타겟팅된 가치 제안이 가장 중요한 영역이 명확해집니다. 용도별로는 페인트-코팅, 퍼스널케어, PVC 안정제, 수처리 분야에서 수요가 나타나고 있습니다. 페인트 및 코팅 용도는 건축용과 산업용, 퍼스널케어 용도는 로션과 샴푸, 수처리 용도는 산업용과 지자체용으로 나뉩니다. 이러한 용도의 차이는 각 최종 용도에 따라 고유한 배합 제약과 문서화 요구 사항을 만들어 냅니다.

공급, 품질 보증, 시장 진입에 영향을 미치는 요인, 북미, 남미, 유럽, 중동 및 아프리카, 아시아태평양의 지역별 수요 동향 및 규제 차이

지역별 동향은 규제에 대한 기대, 공급망 구조, 상업적 보급률을 형성하는 데 결정적인 역할을 하고 있습니다. 북미와 남미에서는 규제 프레임워크와 조달 관행에서 추적성, 문서화된 안전 데이터, 그리고 탄탄한 공급업체와의 파트너십을 중시하는 경우가 많으며, 그 결과 일관된 규정 준수와 신속한 기술 지원을 입증할 수 있는 공급업체가 우대받습니다. 또한, 고도의 다운스트림 제조 산업의 존재와 산업용 최종 사용자의 탄탄한 기반은 더 높은 사양의 제품과 신속한 기술 대응에 대한 수요를 창출하고 있습니다.

주요 제조업체 간의 기업 전략, 혁신 포트폴리오 및 파트너십 모델이 경쟁적 포지셔닝과 공급 탄력성을 재구축하고 있습니다.

주요 생산자 및 유통업체의 기업 전략은 기술 차별화, 규제 과학에 대한 투자, 공급망 탄력성 등 세 가지 핵심 요소에 초점을 맞추었습니다. 업계 선도 기업들은 고급 용도 지원에 자원을 투입하고, 고객의 배합 최적화 및 규제 관련 문서 작성을 지원할 수 있는 역량 센터를 확장하고 있습니다. 이러한 서비스 지향적 투자는 고객과의 관계를 강화하고, 다운스트림 배합업체에 대한 전환 장벽을 구축할 수 있습니다.

복잡한 규제 환경에서 제조업체와 공급업체가 조달, 규정 준수, 지속가능성 노력 및 상업적 성장을 최적화할 수 있도록 명확하고 실행 가능한 단계를 제시합니다.

업계 리더 기업들은 현재의 환경에서 경쟁력과 사업 운영의 탄력성을 강화하기 위해 구체적이고 우선순위를 정한 행동을 취할 수 있습니다. 첫째, 조달과 R&D를 명확한 공급업체 탄력성 프로그램, 주요 중간체 다중 조달, 시나리오 기반 재고 전략, 무역 혼란 시 유연성을 보장하는 계약 조항을 포함한 명확한 공급업체 탄력성 프로그램과 일치시켜야 합니다. 이를 통해 단일 장애점으로 인한 리스크를 줄이고, 무역 정책 전환 시 신속한 경로 변경이 가능합니다.

분석의 엄격성과 타당성을 보장하기 위한 데이터 수집, 전문가 참여, 삼각 검증 및 검증 방법을 설명하는 견고한 조사 방법론 개요

본 조사는 조사의 깊이, 타당성 및 실용적 관련성을 보장하기 위해 혼합된 조사 방법을 채택했습니다. 1차 데이터 수집에는 제제 제조업체, 최종 용도 제조업체 및 공급업체에 걸친 기술 책임자, 조달 책임자 및 규제 전문가를 대상으로 한 구조화된 인터뷰가 포함됐습니다. 이러한 인터뷰는 현장의 취급, 포장 및 물류 관행을 관찰하기 위한 현장 방문 및 업무 감사를 통해 보완되어 위험 감소를 위한 권고안을 제시하는 데 도움이 되는 맥락적 지식을 제공합니다.

조달, 제품 개발, 규제 대응 계획에서 경영진의 의사결정을 지원하기 위한 주요 연구 결과와 전략적 시사점을 간결하게 요약한 보고서입니다.

이러한 분석을 종합해 보면, 분명한 필요성이 부각됩니다. 즉, 진화하는 금속 살생물제 시장에서 성공하기 위해서는 기술적 우수성, 입증 가능한 컴플라이언스, 그리고 강력한 조달 시스템을 통합해야 합니다. 규제 동향과 지속가능성에 대한 기대는 전통적인 성능 기준과 마찬가지로 조달 결정에 있어 중요한 역할을 하고 있으며, 어느 한 측면을 소홀히 하는 기업은 시장 진입에 있어 더 큰 장벽에 직면하게 될 것입니다. 동시에, 전달 시스템 및 저용량 성능의 기술적 발전은 안전성과 규제 준수를 희생하지 않으면서도 차별화를 이룰 수 있는 기회를 제공합니다.

자주 묻는 질문

  • 금속 살생물제 시장 규모는 어떻게 예측되나요?
  • 금속 살생물제 시장의 주요 동향은 무엇인가요?
  • 미국의 관세 조치가 금속 살생물제 시장에 미치는 영향은 무엇인가요?
  • 금속 살생물제 시장에서의 기술 혁신은 어떤 방향으로 진행되고 있나요?
  • 금속 살생물제 시장의 주요 제조업체들은 어떤 전략을 취하고 있나요?

목차

제1장 서문

제2장 조사 방법

제3장 주요 요약

제4장 시장 개요

제5장 시장 인사이트

제6장 미국의 관세 누적 영향(2025년)

제7장 AI의 누적 영향(2025년)

제8장 금속 살생물제 시장 : 유형별

제9장 금속 살생물제 시장 : 형태별

제10장 금속 살생물제 시장 : 용도별

제11장 금속 살생물제 시장 : 최종 이용 산업별

제12장 금속 살생물제 시장 : 유통 채널별

제13장 금속 살생물제 시장 : 지역별

제14장 금속 살생물제 시장 : 그룹별

제15장 금속 살생물제 시장 : 국가별

제16장 미국의 금속 살생물제 시장

제17장 중국의 금속 살생물제 시장

제18장 경쟁 구도

KTH 26.04.13

The Metal Biocides Market was valued at USD 4.18 billion in 2025 and is projected to grow to USD 4.43 billion in 2026, with a CAGR of 6.31%, reaching USD 6.41 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.18 billion
Estimated Year [2026] USD 4.43 billion
Forecast Year [2032] USD 6.41 billion
CAGR (%) 6.31%

Concise orientation to the metal biocides market dynamics that frames regulatory pressures, innovation drivers, and end-user demand shaping strategic decisions

The metal biocides landscape sits at the intersection of legacy chemistry, evolving regulation, and rising demand for durable antimicrobial performance. Recent years have accelerated scrutiny on ingredient safety and environmental persistence, prompting formulators and downstream users to reassess raw material sourcing, substitution pathways, and compliance obligations. At the same time, innovations in application-specific chemistries and delivery systems are opening new performance advantages across coatings, polymer stabilization, personal care, and water treatment contexts.

Stakeholders now navigate a more dynamic supply environment in which procurement decisions must balance functional efficacy, regulatory acceptance, and reputational risk. This shift has elevated cross-functional collaboration between R&D, regulatory affairs, procurement, and commercial teams. Where procurement once prioritized cost and lead-time, it now must incorporate deeper supplier audits and traceability requirements to support product claims. Likewise, R&D groups are being asked to pursue compatibility with sustainability frameworks and to design for lower environmental persistence without compromising antimicrobial performance.

Against this backdrop, executives must understand how regulatory trajectories, technological substitution, and evolving end-user expectations combine to reshape competitive advantage. Strategic clarity on these forces is essential for resilient sourcing, targeted innovation, and defensible product positioning in sectors that increasingly demand both performance and demonstrable safety.

How transformative technological, regulatory, and sustainability transitions are redefining performance, sourcing, and competitive differentiation across metal biocide value chains

Transformative shifts are remapping the value chain from raw materials through to finished formulations, driven by tightened regulation, sustainability commitments, and targeted innovation. Regulatory bodies have intensified focus on environmental fate, human exposure, and long-term persistence, prompting suppliers to invest in alternative chemistries, more robust toxicology datasets, and stewardship programs. Concurrently, original equipment manufacturers and applicators increasingly prioritize life-cycle impacts and demonstrable performance, nudging formulators toward low-dose solutions and encapsulation technologies that reduce environmental release.

Technological advances are enabling higher performance with lower active loadings, using engineered carriers and microencapsulation to extend efficacy while improving compatibility with modern formulation systems. These advances are unfolding alongside supply chain realignment: strategic sourcing partnerships and enhanced supplier transparency are becoming prerequisites for long-term contracts. On the demand side, customers in construction, healthcare, marine, and automotive are requesting documented safety and compliance evidence as part of procurement specifications, making technical support and regulatory expertise a commercial differentiator.

Taken together, these forces accelerate consolidation of best practices around sourcing, compliance documentation, and application-specific R&D. Companies that proactively invest in validated safer alternatives, robust regulatory dossiers, and supply chain resilience position themselves to meet elevated buyer expectations and to secure preferential supplier status across critical end-use segments.

Anticipating the cumulative operational, cost, and supply chain consequences of new US tariff measures and trade policy shifts on metal biocide sourcing and logistics

The layered introduction of tariff measures and trade policy adjustments can propagate through procurement, logistics, and pricing mechanisms, prompting firms to reassess supplier footprints and inventory strategies. Tariff-induced cost shifts tend to magnify when combined with existing constraints such as raw material concentration, transportation bottlenecks, or limited substitution options for functional actives. In response, procurement teams often pursue geographic diversification, nearshoring, or multi-sourcing tactics to mitigate single-country exposures and to preserve continuity of supply.

Operational consequences extend beyond landed cost. Tariff volatility drives tighter inventory management, demand smoothing, and renegotiation of long-term contracts. Firms that integrate scenario planning into procurement and commercial modeling are better placed to preserve margin and maintain service levels under trade stress. Logistics routing and lead times change as shippers reroute to avoid tariffed nodes, increasing complexity in customs compliance and creating additional latency in replenishment cycles.

For manufacturers and formulators, the cumulative effect is a renewed emphasis on supplier risk audits, dual-sourcing of critical intermediates, and contractual flexibility to share or mitigate unexpected cost shifts. Investment in transparent traceability and certification mechanisms reduces friction at customs and procurement gates, while near-term tactical measures such as temporary hedging of input volumes can smooth operational response during periods of heightened trade uncertainty.

Strategic segmentation perspectives that reveal application, type, form, end-use industry, and distribution channel implications for product positioning and R&D priorities

Disaggregating the business through rigorous segmentation reveals where technical requirements and commercial levers differ sharply and where targeted value propositions matter most. When viewed by application, demand emerges across Paints & Coatings, Personal Care, PVC Stabilizers, and Water Treatment, with the Paints & Coatings application further separating into Architectural and Industrial uses and the Personal Care application splitting into Lotion and Shampoo categories while Water Treatment divides into Industrial and Municipal applications. These application distinctions drive formulation constraints and documentation needs that are unique to each end use.

Examining product type highlights a smaller set of primary chemistries, with the market studied across Copper and Zinc Pyrithione, each presenting distinct efficacy profiles, regulatory considerations, and compatibility factors that influence supplier selection. Form considerations split between Liquid and Solid presentations, and the choice between these forms affects handling, dosing precision, and logistics. End use industry segmentation spans Automotive, Construction, Healthcare, and Marine, with Construction further categorized into Commercial and Residential projects, each with different specification cycles and procurement thresholds. Finally, distribution channel analysis distinguishes Offline and Online pathways: Offline encompasses Distributors and Retailers while Online splits into Direct Sales and E Commerce Platforms, and channel choice influences customer support models, lead times, and pricing dynamics.

Understanding these intersecting segmentation vectors enables companies to tailor technical services, documentation packages, and sales strategies to the specific demands of each slice of the market, thereby improving conversion rates and reducing post-sale friction.

Regional demand trajectories and regulatory contrasts across Americas, Europe Middle East and Africa, and Asia-Pacific that influence supply, quality assurance, and market access

Regional dynamics play a decisive role in shaping regulatory expectations, supply chain architecture, and commercial adoption rates. In the Americas, regulatory frameworks and procurement practices often emphasize traceability, documented safety data, and robust supplier partnerships, which in turn favor suppliers who can demonstrate consistent compliance and rapid technical support. The presence of advanced downstream manufacturing and a strong base of industrial end users also creates demand for higher-specification products and faster technical turnaround.

Europe, Middle East & Africa present a complex regulatory mosaic where harmonized standards coexist with region-specific requirements. Companies operating here must navigate stringent environmental testing protocols alongside diverse national implementation timelines. Commercially, the region rewards transparent supply chains and demonstrable reductions in environmental persistence, encouraging innovation in formulation strategies that lower overall chemical footprints.

Asia-Pacific combines manufacturing scale with rapidly evolving regulatory frameworks and strong growth in end-user segments such as construction and personal care. This region often leads in production capacity and can be a source for cost-competitive supply, but buyers increasingly require validated compliance documentation and supplier stewardship programs. Across regions, firms that tailor their compliance dossiers, logistics planning, and customer support to local expectations will gain a durable advantage in market access and customer retention.

Corporate strategic moves, innovation portfolios, and partnership models among leading producers that are reshaping competitive positioning and supply resilience

Corporate strategies among leading producers and distributors emphasize three core pillars: technical differentiation, regulatory science investment, and supply chain resilience. Industry leaders are channeling resources into advanced application support, expanding capability centers that can assist customers with formulation optimization and regulatory dossier preparation. These service-oriented investments strengthen customer relationships and create barriers to switching for downstream formulators.

On the innovation front, firms are balancing incremental improvements to established chemistries with exploratory programs focused on lower persistence actives and improved delivery technologies. Strategic partnerships and targeted acquisitions are common approaches to fill capability gaps quickly, enabling faster time-to-market for new solutions. In parallel, several companies are enhancing their upstream integration to secure critical intermediates and to reduce exposure to concentrated supplier networks.

Commercially, successful organizations are differentiating through transparent documentation, proactive regulatory engagement, and tiered support models that match service level to customer value. Those that combine technical leadership with robust compliance platforms and diversified sourcing networks are better positioned to meet complex RFPs, respond to regulatory inquiries, and support customers seeking to demonstrate safer product credentials.

Clear, actionable steps for manufacturers and suppliers to optimize sourcing, compliance, sustainability initiatives, and commercial growth in complex regulatory environments

Industry leaders can take concrete, prioritized actions to strengthen competitive position and operational resilience in the current environment. First, align procurement and R&D with an explicit supplier resilience program that includes multi-sourcing of critical intermediates, scenario-based inventory strategies, and contractual clauses that provide flexibility under trade disruptions. This reduces the risk of single-point failures and enables faster rerouting when trade policy shifts occur.

Second, invest in regulatory science and dossier completeness early in the product lifecycle. Comprehensive safety data packages and proactive engagement with regulatory agencies reduce approval friction and support customer confidence. Supplementary technical services, including customized compatibility testing and application guidance, create tangible value for customers and help justify premium positioning.

Third, adopt sustainability and stewardship narratives that are evidence-based and auditable. Demonstrable reductions in environmental persistence, transparent life-cycle documentation, and third-party certifications can open doors in procurement processes that increasingly weigh environmental credentials. Finally, recalibrate commercial models for channel specificity: enhance distributor training and technical support for Offline channels while optimizing digital content, fulfillment, and direct engagement for Online channels to improve conversion and retention.

Robust research methodology overview explaining data collection, expert engagement, triangulation, and validation approaches that ensure analytical rigor and relevance

The research draws on a mixed-methods approach designed to ensure depth, validity, and practical relevance. Primary data collection included structured interviews with technical leaders, procurement heads, and regulatory specialists across formulation houses, end-use manufacturers, and suppliers. These interviews were complemented by targeted field visits and operational audits to observe handling, packaging, and logistics practices in situ, providing contextual insights that inform risk mitigation recommendations.

Secondary research encompassed regulatory filings, peer-reviewed toxicology literature, patent landscapes, and product technical bulletins to assemble a comprehensive view of ingredient performance characteristics and compliance pathways. Triangulation techniques matched primary observations with documentary evidence to validate claims and to resolve discrepancies. Supply chain mapping and scenario analysis were employed to stress-test sourcing strategies under different trade and logistics conditions, while comparative case studies illustrated successful mitigation tactics.

Analytical frameworks included driver-impact matrices, value chain decomposition, and a capability gap assessment to highlight priority areas for investment. Throughout, data integrity checks and expert validation rounds ensured that conclusions reflect robust, current evidence and practical applicability for decision-makers.

Concise synthesis of core findings and strategic implications to inform executive decision-making across procurement, product development, and regulatory planning

The cumulative analysis underscores a clear imperative: companies must integrate technical excellence with demonstrable compliance and resilient sourcing to succeed in the evolving metal biocide space. Regulatory dynamics and sustainability expectations now play as large a role as traditional performance criteria in procurement decisions, and firms that neglect either dimension will face increased friction in market access. Simultaneously, technological advances in delivery systems and low-dose performance present opportunities to differentiate without sacrificing safety or regulatory compliance.

Operationally, supply chain diversification, stronger supplier relationships, and scenario-based procurement planning emerge as foundational capabilities to manage trade and logistical volatility. Commercially, tailored value propositions that combine technical support, thorough documentation, and channel-appropriate service models will accelerate adoption and build long-term partnerships with downstream customers. Strategic investments into regulatory science and transparent stewardship programs not only reduce compliance risk but also materially enhance commercial credibility.

Executives should therefore prioritize a coordinated program that links R&D, regulatory affairs, procurement, and commercial functions. This integrated approach will enable organizations to capture demand in segments with the highest technical and compliance requirements while maintaining flexibility to respond swiftly to policy or trade shifts.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Metal Biocides Market, by Type

  • 8.1. Copper
  • 8.2. Zinc Pyrithione

9. Metal Biocides Market, by Form

  • 9.1. Liquid
  • 9.2. Solid

10. Metal Biocides Market, by Application

  • 10.1. Paints & Coatings
    • 10.1.1. Architectural
    • 10.1.2. Industrial
  • 10.2. Personal Care
    • 10.2.1. Lotion
    • 10.2.2. Shampoo
  • 10.3. PVC Stabilizers
  • 10.4. Water Treatment
    • 10.4.1. Industrial
    • 10.4.2. Municipal

11. Metal Biocides Market, by End Use Industry

  • 11.1. Automotive
  • 11.2. Construction
    • 11.2.1. Commercial
    • 11.2.2. Residential
  • 11.3. Healthcare
  • 11.4. Marine

12. Metal Biocides Market, by Distribution Channel

  • 12.1. Offline
    • 12.1.1. Distributors
    • 12.1.2. Retailers
  • 12.2. Online
    • 12.2.1. Direct Sales
    • 12.2.2. E Commerce Platforms

13. Metal Biocides Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Metal Biocides Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Metal Biocides Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Metal Biocides Market

17. China Metal Biocides Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Arxada AG
  • 18.6. Azelis group
  • 18.7. BASF SE
  • 18.8. Chemtex Speciality Ltd.
  • 18.9. Clariant AG
  • 18.10. Dadia Chemical Industries
  • 18.11. H2O Innovation Inc.
  • 18.12. King Industries, Inc.
  • 18.13. LANXESS AG
  • 18.14. Lonza Group Ltd.
  • 18.15. Nouryon Chemicals Holding B.V.
  • 18.16. Otto Chemie Pvt. Ltd.
  • 18.17. Pilot Chemical Company
  • 18.18. SANITIZED AG
  • 18.19. Solvay S.A.
  • 18.20. Stepan Company
  • 18.21. The Lubrizol Corporation
  • 18.22. U.S. Steriles
  • 18.23. Vink Chemicals GmbH & Co. KG
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제